Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-034821
Filing Date
2025-11-13
Accepted
2025-11-13 16:09:04
Documents
53
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi20250930_10q.htm   iXBRL 10-Q 1105662
2 EXHIBIT 31.1 ex_855996.htm EX-31.1 12900
3 EXHIBIT 31.2 ex_855997.htm EX-31.2 12877
4 EXHIBIT 32.1 ex_855998.htm EX-32.1 4973
5 EXHIBIT 32.2 ex_855999.htm EX-32.2 4941
  Complete submission text file 0001437749-25-034821.txt   5034985

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20250930.xsd EX-101.SCH 51216
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20250930_cal.xml EX-101.CAL 21004
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20250930_def.xml EX-101.DEF 320912
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20250930_lab.xml EX-101.LAB 310062
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20250930_pre.xml EX-101.PRE 344079
56 EXTRACTED XBRL INSTANCE DOCUMENT atxi20250930_10q_htm.xml XML 668331
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 251478493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)